These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6756445)

  • 21. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
    Ohman KP; Karlberg BE; Nilsson OR; Wettre S
    Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of angiotensin converting enzyme inhibitor on serum aldosterone and potassium level.
    Kamei H; Arakawa K
    Jpn Heart J; 1982 Mar; 23(2):191-9. PubMed ID: 7043022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Haemodynamic responses to specific renin-angiotensin inhibitors in hypertension and congestive heart failure. A review.
    Cody RJ
    Drugs; 1984 Aug; 28(2):144-69. PubMed ID: 6205842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Participation of the renin system in treatment-resistant hypertension as measured by acute blockade of the angiotensin converting enzyme.
    Weber MA; Drayer JI; Priest RT; Chen TC
    Am J Nephrol; 1982; 2(1):6-11. PubMed ID: 6295161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haemodynamic effects of captopril in acute left ventricular failure complicating myocardial infarction.
    McAlpine HM; Morton JJ; Leckie B; Dargie HJ
    J Cardiovasc Pharmacol; 1987; 9 Suppl 2():S25-30. PubMed ID: 2441196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.
    Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of captopril on pulmonary arterial hypertension in congestive heart failure associated with chronic obstructive bronchopneumopathy].
    Saadjian A; Philip-Joet F; Allard-Latour G; Arnaud A; Torresani J
    Rev Pneumol Clin; 1984; 40(5):321-5. PubMed ID: 6395282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Captopril as treatment for patients with pulmonary hypertension. Problem of variability in assessing chronic drug treatment.
    Rich S; Martinez J; Lam W; Rosen KM
    Br Heart J; 1982 Sep; 48(3):272-7. PubMed ID: 7049203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haemodynamic and neurohumoral response to exercise in patients with congestive heart failure treated with captopril.
    Creager MA; Faxon DP; Weiner DA; Ryan TJ
    Br Heart J; 1985 Apr; 53(4):431-5. PubMed ID: 3885981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyponatraemic hypertensive syndrome with renal-artery occlusion corrected by captopril.
    Atkinson AB; Davies DL; Leckie B; Morton JJ; Brown JJ; Fraser R; Lever AF; Robertson JI
    Lancet; 1979 Sep; 2(8143):606-9. PubMed ID: 90271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endogenous prostaglandin E2 metabolite levels, renin-angiotensin system and catecholamines versus acute hemodynamic response to captopril in chronic congestive heart failure.
    Silberbauer K; Punzengruber C; Sinzinger H
    Cardiology; 1983; 70(6):297-307. PubMed ID: 6370431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Captopril in renovascular hypertension: long-term use in predicting surgical outcome.
    Atkinson AB; Brown JJ; Cumming AM; Fraser R; Lever AF; Leckie BJ; Morton JJ; Robertson JI
    Br Med J (Clin Res Ed); 1982 Mar; 284(6317):689-93. PubMed ID: 6802290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of captopril (SQ 14,225) in a patient with primary pulmonary hypertension.
    Horowitz JD; Brennan JB; Oliver LE; Harding D; Goble AJ; Louis WJ
    Postgrad Med J; 1981 Feb; 57(664):115-6. PubMed ID: 7022422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluctuations in the plasma angiotensin I converting enzyme activity during long-term treatment with captopril.
    Staessen J; Fagard R; Lijnen P; Verschueren LJ; Amery A
    Acta Cardiol; 1982; 37(1):1-9. PubMed ID: 6282024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of captopril on the activities of angiotensin II and angiotensin converting enzyme during hypoxia induced pulmonary hypertension].
    Chen SC
    Zhonghua Jie He He Hu Xi Za Zhi; 1990 Oct; 13(5):271-3, 317. PubMed ID: 1964875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of SQ 14.225, an orally active inhibitor of angiotensin-converting enzyme, on hypoxic pulmonary hypertension and right ventricular hypertrophy in rats.
    Kentera D; Susić D; Cvetković A; Djordjević G
    Basic Res Cardiol; 1981; 76(3):344-51. PubMed ID: 6455994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemodynamic effects of captopril in pulmonary hypertension of collagen vascular disease.
    Niarchos AP; Whitman HH; Goldstein JE; Laragh JH
    Am Heart J; 1982 Oct; 104(4 Pt 1):834-8. PubMed ID: 6751058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of captopril in patients with chronic obstructive pulmonary disease and secondary pulmonary hypertension.
    Patakas D; Georgopoulos D; Rodini H; Christaki P
    Postgrad Med J; 1988 Mar; 64(749):193-5. PubMed ID: 3050941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The hypotensive effect of propranolol in captopril-treated patients does not involve the plasma renin--angiotensin--aldosterone system.
    Staessen J; Fagard R; Lijnen P; Verschueren LJ; Amery A
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():441s-444s. PubMed ID: 7032826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of the angiotensin converting enzyme inhibitor, captopril (SQ14,225), on orthostatic sodium and water retention in patients with idiopathic edema.
    Suzuki H; Fujimaki M; Nakane H; Saito I; Takeshita E; Saruta T
    Nephron; 1985; 39(3):244-9. PubMed ID: 2983253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.